Table 1.
12/28/17+ | 2/23/20 PCD 4 | 2/24/20 PCD 5∗ | 2/27/20 PCD 8 | 2/28/20 PCD 9∗∗ | 2/29/20 PCD 10 | 3/1/20 PCD11 | 3/6/20 PCD16∗∗∗ | 3/11/20 PCD 21∗∗∗∗ | |
---|---|---|---|---|---|---|---|---|---|
TSH (uIU/ml) 0.6–4.8 | 1.165 | <0.0008 | <0.0008 | 0.0009 | 0.008 | 0.009 | 0.008 | 0.011 | 0.822 |
Free T4 (ng/dL) 0.9–1.8 (ng/dL) | 1.0 | 4.1 | 5.1 | 6.8 | 7.4 | 7.0 | 5.2 | 2.4 | 1.3 |
Total T4 (ug/dL) 4.5–10.9 | 15.0 | 16.5 | 26.9 | 26.3 | 24.7 | 21.5 | 8.1 | 6.4 | |
Total T3 (ng/mL) 0.6–1.8 | 1.79 | 1.81 | 4.06 | 3.90 | 2.76 | 1.91 | 0.76 | 1.00 | |
TSI (IU/L) <0.54IU/L | <0.10 | ||||||||
TPO ab (IU/ml) 0.0–9.0 | <0.3 | ||||||||
Tg ag (IU/ml) 0.0–4.0 | <0.9 |
PCD: Post contrast day, +available as baseline from prior GI appointment for poor weight gain, ∗methimazole started, ∗∗hydrocortisone 100 mg q 8/propranolol 40 mg q 8 hours started, ∗∗∗methimazole stopped/Hydrocortisone stopped, ∗∗∗∗propranolol stopped.